Literature DB >> 12618314

Influence of pH on the ototoxicity of cisplatin: a round window application study.

Fujinobu Tanaka1, Craig A Whitworth, Leonard P Rybak.   

Abstract

Cisplatin is an antineoplastic agent that produces a number of dose-limiting side effects, including ototoxicity. We investigated the effect of pH on cisplatin ototoxicity. Auditory brainstem responses (ABR) were recorded in chinchillas. Then the auditory bullae were opened and acidic (pH=6.5), neutral (pH=7.4) or alkaline (pH=10.2) phosphate-buffered saline (PBS) was applied to the round window membrane. After 30 min, any remaining solution was removed and cisplatin solution was applied to the round window membrane. After 3 days, follow-up ABRs were performed and the cochleae were processed for morphological analysis. Neutral PBS+cisplatin administration resulted in profound threshold changes at all frequencies. Acidic PBS+cisplatin administration showed had a trend of increased threshold changes, but the change did not reach statistical significance. However, the degree of hair cell loss was significantly higher than that of the neutral PBS-cisplatin group. Alkaline PBS significantly reduced cisplatin-induced threshold changes (P<0.05) compared to the neutral PBS group. Because the pH of cisplatin solution was 6.0, pH 6.0 PBS was applied to round window membrane. This acidic PBS solution did not cause any hearing impairment. These results demonstrate that pH can modulate the ototoxic effects of cisplatin.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12618314     DOI: 10.1016/s0378-5955(02)00771-2

Source DB:  PubMed          Journal:  Hear Res        ISSN: 0378-5955            Impact factor:   3.208


  15 in total

1.  'Ecstasy' enhances noise-induced hearing loss.

Authors:  Michael W Church; Jinsheng S Zhang; Megan M Langford; Shane A Perrine
Journal:  Hear Res       Date:  2013-05-25       Impact factor: 3.208

Review 2.  Communication pathways to and from the inner ear and their contributions to drug delivery.

Authors:  Alec N Salt; Keiko Hirose
Journal:  Hear Res       Date:  2017-12-19       Impact factor: 3.208

3.  Transtympanic administration of short interfering (si)RNA for the NOX3 isoform of NADPH oxidase protects against cisplatin-induced hearing loss in the rat.

Authors:  Debashree Mukherjea; Sarvesh Jajoo; Tejbeer Kaur; Kelly E Sheehan; Vickram Ramkumar; Leonard P Rybak
Journal:  Antioxid Redox Signal       Date:  2010-09-01       Impact factor: 8.401

4.  TRPV1 regulators mediate gentamicin penetration of cultured kidney cells.

Authors:  Sigrid E Myrdal; Peter S Steyger
Journal:  Hear Res       Date:  2005-06       Impact factor: 3.208

5.  An optimized, clinically relevant mouse model of cisplatin-induced ototoxicity.

Authors:  K Fernandez; T Wafa; T S Fitzgerald; L L Cunningham
Journal:  Hear Res       Date:  2019-02-22       Impact factor: 3.208

6.  Perilymph pharmacokinetics of locally-applied gentamicin in the guinea pig.

Authors:  A N Salt; J J Hartsock; R M Gill; E King; F B Kraus; S K Plontke
Journal:  Hear Res       Date:  2016-10-08       Impact factor: 3.208

7.  NOX3 NADPH oxidase couples transient receptor potential vanilloid 1 to signal transducer and activator of transcription 1-mediated inflammation and hearing loss.

Authors:  Debashree Mukherjea; Sarvesh Jajoo; Kelly Sheehan; Tejbeer Kaur; Sandeep Sheth; Jennifer Bunch; Christopher Perro; Leonard P Rybak; Vickram Ramkumar
Journal:  Antioxid Redox Signal       Date:  2010-12-07       Impact factor: 8.401

8.  Short interfering RNA against transient receptor potential vanilloid 1 attenuates cisplatin-induced hearing loss in the rat.

Authors:  Debashree Mukherjea; Sarvesh Jajoo; Craig Whitworth; Jennifer R Bunch; Jeremy G Turner; Leonard P Rybak; Vickram Ramkumar
Journal:  J Neurosci       Date:  2008-12-03       Impact factor: 6.167

9.  Protection against cisplatin ototoxicity in a Sprague-Dawley rat animal model.

Authors:  P Giordano; G Lorito; A Ciorba; A Martini; S Hatzopoulos
Journal:  Acta Otorhinolaryngol Ital       Date:  2006-08       Impact factor: 2.124

10.  Sodium bicarbonate nanoparticles modulate the tumor pH and enhance the cellular uptake of doxorubicin.

Authors:  Hanan Abumanhal-Masarweh; Lilach Koren; Assaf Zinger; Zvi Yaari; Nitzan Krinsky; Galoz Kaneti; Nitsan Dahan; Yael Lupu-Haber; Edith Suss-Toby; Esther Weiss-Messer; Michal Schlesinger-Laufer; Janna Shainsky-Roitman; Avi Schroeder
Journal:  J Control Release       Date:  2019-01-05       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.